Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity.
about
CARMIL2 is a novel molecular connection between vimentin and actin essential for cell migration and invadopodia formationCell Migration and Invadopodia Formation Require a Membrane-binding Domain of CARMIL2.MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer.Real-time analysis of epithelial-mesenchymal transition using fluorescent single-domain antibodiesIntegrin beta8 (ITGB8) activates VAV-RAC1 signaling via FAK in the acquisition of endometrial epithelial cell receptivity for blastocyst implantation.Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling PathwayVimentin Phosphorylation Underlies Myofibroblast Sensitivity to Withaferin A In Vitro and during Corneal FibrosisVimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation.miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor MicroenvironmentLKB1 kinase-dependent and -independent defects disrupt polarity and adhesion signaling to drive collagen remodeling during invasion.Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones.Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular CarcinomaVimentin intermediate filaments control actin stress fiber assembly through GEF-H1 and RhoA.The roles and regulation of the actin cytoskeleton, intermediate filaments and microtubules in smooth muscle cell migration.Aptamers Selected to Postoperative Lung Adenocarcinoma Detect Circulating Tumor Cells in Human Blood.A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.Upregulated Vav2 in gastric cancer tissues promotes tumor invasion and metastasis.Basic fibroblast growth factor promotes melanocyte migration via activating PI3K/Akt-Rac1-FAK-JNK and ERK signaling pathways.Vimentin Intermediate Filaments Template Microtubule Networks to Enhance Persistence in Cell Polarity and Directed Migration.Emerging roles of RAC1 in treating lung cancer patients.Intermediate Filaments and the Plasma Membrane.STIM1 silencing inhibits the migration and invasion of A549 cells.Estimation of low-dose radiation-responsive proteins in the absence of genomic instability in normal human fibroblast cells.Intermediate Filaments at the Junction of Mechanotransduction, Migration, and Development.Phosphoprotein profiles of candidate markers for early cellular responses to low-dose γ-radiation in normal human fibroblast cells.Zinc induces epithelial to mesenchymal transition in human lung cancer H460 cells via superoxide anion-dependent mechanism.DNA Aptamers for the Characterization of Histological Structure of Lung Adenocarcinoma.GFAPδ/GFAPα ratio directs astrocytoma gene expression towards a more malignant profile.Current and Prospective Protein Biomarkers of Lung Cancer.Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell-Cancer-Associated Fibroblast Interactions during Collective Invasion.Blockade of α7 nicotinic acetylcholine receptors inhibit nicotine-induced tumor growth and vimentin expression in non-small cell lung cancer through MEK/ERK signaling way.The Potential Biomarkers and Immunological Effects of Tumor-Derived Exosomes in Lung Cancer.Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways.FSTL1 interacts with VIM and promotes colorectal cancer metastasis via activating the focal adhesion signalling pathway.Ubiquitin E3 Ligase MARCH7 promotes proliferation and invasion of cervical cancer cells through VAV2-RAC1-CDC42 pathway.Vimentin Diversity in Health and Disease
P2860
Q27305215-156BDC11-31E5-47B0-A7DB-E3CF363AAC91Q28116157-EEC2371D-446C-4592-B06E-338CA86B8DB6Q30009013-065CC2BC-DCFB-48DC-9E37-AADC4937DFDAQ30661925-28E86A28-58AF-4FA4-9E22-6CF73B57ECC8Q33689671-82FEA9E5-2270-4F27-8568-4F6A34121C47Q35711258-DE2290EA-59A8-4CB3-8DED-5F1898881646Q35862259-14DCBC9B-21C4-4426-83E7-6448E916A6CCQ36140688-AA200526-19D6-4C4D-848D-A9F716200D40Q36244787-4D4F6148-72CB-4254-8943-06C3EBD05BA8Q36603426-B3BCA7B7-E26A-4CB1-9F26-B7CBEAD8A6A3Q36746175-FA06BD7D-5BA4-4A26-9DAC-F1B0101D248CQ37536641-011112ED-3B0E-451E-B2AA-ED9F40CCCE7DQ37577606-D6D36A8E-FB53-48A9-A5D8-FCC5DB84688AQ37711551-D222F76F-5D51-4E9A-8D20-BA9B3007DE82Q37742401-9319FCD0-E5D7-4A26-AB6A-F11EA8E2D34BQ38298414-8D12F402-3A3E-4845-8E94-1AB52C53752EQ38647048-7E6C2D93-F880-4C53-B19C-73E64021C3F8Q38705395-A6326DA1-1429-4E72-BCD7-47190B4CA298Q38761387-61728518-AA9A-419A-9E15-76F5FEFB09E4Q38817795-C35886C4-24B1-4BAF-B7E5-380495DE3341Q38993407-A20DD0B8-DEC9-47B0-8A72-1AE6CB01124AQ39066276-A3C9ABA3-A9D6-48E9-9DAE-FA6BCAE7A77BQ40120592-91B4764C-96DB-4DF4-B706-524852D80E37Q40133479-72BDB5D3-4582-417D-8226-3B6609CE8C0EQ41672923-ABF737F8-DA5C-41B1-AC21-5A378467EDA9Q41849082-9FADE146-AD35-4962-9E35-B509016514B0Q41865139-25868B4B-DC66-4E0A-B3D2-26419A4E7335Q41898283-D8251222-CF3B-40E8-A3C1-4EDEA6BB4E09Q47103846-EEC9434E-C32F-4995-BCE6-CDB7E35431A4Q47130839-DBDCFA48-39B2-4DBB-8EBB-1A9F285743ECQ47326534-930741C7-AE9D-455A-9093-05812A9799EFQ49309912-B7C7778A-E723-47D8-B952-53AE366BEAFBQ52714409-00B6F24D-DA4B-4734-87AC-8EDD82DF8549Q55003973-D488EF02-20CA-444E-AC72-CEC69C4C33A0Q55129404-2B90DF84-E906-4521-8F7B-69441F0487A6Q55618419-E8643E7D-7985-4C65-BB5D-737D0B789ADFQ58702541-2EAD8D32-B5D1-4649-83B6-84D635523461
P2860
Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Vimentin regulates lung cancer ...... ocal adhesion kinase activity.
@ast
Vimentin regulates lung cancer ...... ocal adhesion kinase activity.
@en
Vimentin regulates lung cancer ...... ocal adhesion kinase activity.
@nl
type
label
Vimentin regulates lung cancer ...... ocal adhesion kinase activity.
@ast
Vimentin regulates lung cancer ...... ocal adhesion kinase activity.
@en
Vimentin regulates lung cancer ...... ocal adhesion kinase activity.
@nl
prefLabel
Vimentin regulates lung cancer ...... ocal adhesion kinase activity.
@ast
Vimentin regulates lung cancer ...... ocal adhesion kinase activity.
@en
Vimentin regulates lung cancer ...... ocal adhesion kinase activity.
@nl
P2093
P2860
P356
P1433
P1476
Vimentin regulates lung cancer ...... ocal adhesion kinase activity.
@en
P2093
A I Marcus
A M Salgueiro
P2860
P2888
P304
P356
10.1038/ONC.2014.123
P407
P577
2014-05-26T00:00:00Z
P5875
P6179
1029733753